title: Clinical inquiries. Which medications benefit patients with diastolic heart failure?
authors.affiliation: Virginia Commonwealth, University-Shenandoah Valley Family Practice Residency, Front Royal, VA, USA.
authors.forename: Micah
authors.initials: M
authors.lastname: Crouse
authors.forename: David
authors.initials: D
authors.lastname: Flack
authors.forename: J William
authors.initials: JW
authors.lastname: Kerns
authors.forename: Larisa
authors.initials: L
authors.lastname: Martin
authors.forename: Daniel
authors.initials: D
authors.lastname: Pham
authors.forename: Ramashilpa
authors.initials: R
authors.lastname: Sudireddy
authors.forename: Karen
authors.initials: K
authors.lastname: Knight
mesh_terms: D057911:Angiotensin Receptor Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D019317:Evidence-Based Medicine; D005665:Furosemide / Q000627:therapeutic use; D054144:Heart Failure, Diastolic / Q000188:drug therapy* / Q000401:mortality; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic; D011433:Propranolol / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
chemical_list: D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D005665:Furosemide; D011433:Propranolol